Skip to main content

Predicta Biosciences

Boston, United States

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

$23.4M raised
Oct 2025
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Predicta Biosciences

How much funding has Predicta Biosciences raised?
Predicta Biosciences has raised $23.4M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Who are Predicta Biosciences's investors?
Predicta Biosciences's investors include Engine Ventures, Illumina Ventures, Mass General Brigham Ventures, BrightEdge - American Cancer Society, Binney Street Capital.
Where is Predicta Biosciences headquartered?
Predicta Biosciences is headquartered in Boston, United States.
What does Predicta Biosciences do?
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.
What stage is Predicta Biosciences at?
Predicta Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Predicta Biosciences — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/predicta-biosciences. Accessed July 3, 2026.
APA
VCBacked. (2025). Predicta Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/predicta-biosciences
Wikipedia (cite web)
{{cite web |title=Predicta Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/predicta-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .